After intestinal surgery, you lose the ability to absorb nutrients properly. Teduglutide is an FDA-approved peptide that actually regenerates the remaining intestine to help your body absorb nutrients again - reducing or eliminating the need for parenteral nutrition.
Written by — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Nutrients passing straight through without absorption
error
Malabsorption
Unable to get nutrients from food no matter what you eat
vaccines
Parenteral Nutrition Dependent
Requires IV feeding just to survive with serious infection risks
Understanding Intestinal Adaptation
After Surgery: The Absorption Crisis
Your intestines are where the magic happens - where your body breaks down food and absorbs nutrients into your bloodstream. The small intestine has villi - tiny finger-like projections that increase surface area for absorption. They're incredibly efficient.
When you have surgery to remove significant portions of your small intestine - whether due to Crohn's disease, tumor removal, trauma, or vascular issues - you suddenly lose massive absorption capacity. The remaining intestine tries to compensate through a process called intestinal adaptation, where the remaining villi grow taller and broader. But adaptation has limits.
Without enough absorbing surface area, you can't get adequate calories, protein, vitamins, and minerals from food, no matter how much you eat. This leads to parenteral nutrition (PN) - essentially feeding yourself intravenously through a central line.
format_quoteParenteral nutrition is life-saving but comes with serious risks: infections, blood clots, and liver disease from long-term use.
This is where teduglutide and GLP-2 analogs come in - they're not trying to replace missing intestine, they're trying to maximize what you have left. By stimulating growth of the remaining intestinal tissue, they help you absorb more nutrients from food and reduce or eliminate PN dependence.
spa
FDA Approved 2012
Teduglutide (Gattex)
FDA-Approved Intestinal Growth Factor
A recombinant analog of GLP-2 (glucagon-like peptide-2) that directly stimulates growth and blood flow to remaining intestinal tissue.
Its role
Fertilizer for your intestines - makes them grow bigger and more absorptive
Typical range
0.05 mg/kg once daily
The bottom line
Teduglutide is literally FDA-approved to help your remaining intestine grow and absorb more nutrients, allowing you to reduce or eliminate dependence on parenteral nutrition.
bolt
1996
GLP-2 Analogs (Teduglutide)
Natural Gut Growth Signals
Glucagon-like peptide-2 and its analogs are endogenous hormones that signal your intestine to grow and improve function. Teduglutide is the most clinically advanced, but other analogs exist.
Its role
The communication signal that tells intestines 'grow and work better'
Typical range
0.05 mg/kg daily
The bottom line
GLP-2 is a natural hormone your gut produces that promotes intestinal adaptation and healing. Using GLP-2 and its analogs essentially amplifies your body's own recovery mechanism.
eco
1991
BPC-157
The Gut Healing Peptide
A synthetic peptide based on a protective sequence found in gastric juice. Promotes healing of the entire GI tract through multiple mechanisms.
Its role
Comprehensive repair and regeneration system for gut tissue
Typical range
250-500 mcg per dose
The bottom line
BPC-157 supports healing of remaining intestinal tissue through angiogenesis, growth factor signaling, and gut barrier reinforcement - complementary to teduglutide's growth stimulation.
An honest breakdown based on research and clinical reports.
schedule
Phase 1 of 5
Week 1-4
The Starting Phase
What's happening inside
Teduglutide and other peptides are beginning to signal intestinal growth, but you're still early in the adaptation process. GLP-2 receptors on intestinal cells are being activated.
What you might notice
Possibly no dramatic changes yet - this is normal
Some patients report slight energy improvements
Possible subtle changes in bowel consistency
Appetite changes (often improvements) as gut signals improve
warning Watch for
Some patients experience mild cramping or increased stool frequency initially as the intestine begins responding. This typically resolves in 1-2 weeks.
Realistic expectations
You're initiating growth signals. Give it time to compound.
trending_up
Phase 2 of 5
Month 1-2
Early Adaptation
What's happening inside
Intestinal villi are beginning to lengthen. Mesenteric blood flow is improving. Your remaining intestine is responding to the growth signals.
What you might notice
Stool frequency and consistency may improve
Diarrhea may decrease noticeably
First signs of improved nutrient absorption (better energy, less mineral losses)
Possible reduction in PN requirements (detected through labs)
Improved tolerance to food variety
warning Watch for
Track stool patterns carefully - they're your feedback mechanism. Monitor weight (stabilization is a good sign). Work with your PN team on adjustments.
Realistic expectations
Early signs of improvement should be becoming visible. Some patients see measurable PN reduction by month 2.
auto_awesome
Phase 3 of 5
Month 2-3
Building Momentum
What's happening inside
Intestinal adaptation is accelerating. Villi continue lengthening. Mucosal surface area is expanding. Your remaining bowel is becoming more functional.
What you might notice
Significant improvements in stool consistency and frequency
Measurable reduction in diarrhea
More substantial reductions in PN requirements starting to become clear
Better food tolerance - can handle wider variety
Improved energy and less fatigue
Lab improvements in nutrient absorption markers
warning Watch for
This is when many patients start reducing PN. Do this gradually under medical supervision with regular lab monitoring.
Realistic expectations
Significant functional improvement. Many patients see 20-50% reduction in PN requirements by this phase.
check_circle
Phase 4 of 5
Month 3-6
Consolidation Phase
What's happening inside
Intestinal regeneration is substantial. Remaining bowel function has improved dramatically. Many patients achieve significant PN reduction or independence.
What you might notice
Most patients see major reductions in diarrhea
Food absorption improved noticeably - can eat like someone with a normal bowel
PN requirements often reduced by 50% or eliminated entirely for some patients
Central line no longer needed for many
Dramatic quality of life improvement - freedom from PN dependence
Resumption of normal eating patterns
warning Watch for
If reducing PN significantly, monitor closely for nutritional status. Some patients need carefully titrated PN reduction.
Realistic expectations
This is where the real benefit becomes clear. Teduglutide clinical trials showed average PN volume reduction of 40%. Some patients achieve full independence.
auto_awesome
Phase 5 of 5
6-12 Months
Long-Term Benefit
What's happening inside
Intestinal adaptation is consolidated. Your remaining bowel is functioning at optimized capacity. With continued teduglutide, benefits are maintained or continue improving.
What you might notice
Sustained improvements in absorption and function
Many patients remain off PN entirely
Some who needed PN can maintain on minimal supplemental nutrition
Normal quality of life restored for most patients
Dramatically reduced infection risk compared to PN dependence
No more liver disease progression risk from PN
Realistic expectations
You've achieved significant functional recovery. Your remaining intestine is working as well as it can with optimal stimulation.
General guidelines based on research literature and clinical reports. Work with a healthcare provider experienced in peptide therapy to customize for your situation.
warningImportant: These are general guidelines. Don't self-prescribe based on internet articles. Work with a qualified healthcare provider.
Teduglutide (Gattex) · typical range
0.05mg
/kg once daily
Common protocols
medicationStandard FDA-approved dose: 0.05 mg/kg subcutaneous injection once daily
medicationAverage adult dose: 3-5 mg once daily (based on body weight)
medicationUsually dosed in the evening or with meals
Timing considerations
scheduleOnce daily subcutaneous injection
scheduleEvening dosing is most common
scheduleCan be dosed at any consistent time
scheduleTake with consistent meal timing for better nutrient absorption response
repeat Cycling
Typically used continuously as long as benefits persist
GLP-2 Analogs (Teduglutide) · typical range
0.05mg
/kg daily
Common protocols
medicationTeduglutide (Gattex): FDA-approved at 0.05 mg/kg daily
medicationOther GLP-2 analogs: Under research in clinical trials
medicationStarting typically occurs gradually with medical supervision
Timing considerations
scheduleDaily dosing provides consistent stimulation of adaptation
scheduleEvening injection allows growth processes during sleep
scheduleConsistent timing with meals helps maximize nutrient absorption from food
scheduleMost effective with coordinated nutritional support
repeat Cycling
Continuous use - treatment is maintained as long as benefits persist and patient tolerates
medicationConservative: 250 mcg daily subcutaneous injection
medicationStandard: 250-500 mcg daily (some protocols use 500 mcg twice daily)
medicationOften combined with teduglutide for complementary action
Timing considerations
scheduleCan be taken at any time, though morning dosing is often preferred
scheduleOral BPC-157 is available and may be preferred by some (250-500 mcg daily)
scheduleConsistency of dosing more important than specific timing
scheduleSome evidence suggests taking with meals may improve absorption for oral form
repeat Cycling
Often cycled 8-12 weeks on, 4 weeks off due to preclinical status. Some practitioners use continuous low-dose protocols.
Practical tips
vaccinesInjection basics
Subcutaneous injections go into fatty tissue (belly, thigh, back of arm)
Rotate injection sites to prevent tissue irritation
Use insulin syringes (29-31 gauge) for comfort
Clean the injection site with alcohol first
Pinch skin, insert needle at 45-90 degree angle, inject slowly
If you have a central line for PN, teduglutide injects subcutaneously - different from your PN line
ac_unitStorage
Teduglutide (Gattex) comes as a powder vial
After reconstitution, typically stable for 3-4 weeks refrigerated
Keep away from light and heat
Never freeze reconstituted peptides
Unreconstituted powder vials are stable longer
Consistency in storage maintains efficacy
water_dropReconstitution
Use bacteriostatic water (provided with kit)
Inject water slowly down the side of the vial
Swirl gently - never shake vigorously
Wait until fully dissolved before using
Each vial contains 5 mg teduglutide (typical adult dose)
Ask your pharmacist or prescriber if you're unsure
Peptides work best as part of a comprehensive approach.
nutrition
Nutrition
Fueling Mitochondria
Your mitochondria need specific nutrients to function. Chronic illness often depletes these.
The basics that matter
Anti-inflammatory eating
Focus on vegetables, quality proteins, healthy fats. Minimize sugar, processed foods, and seed oils.
Blood sugar stability
Wild blood sugar swings stress mitochondria. Eat protein and fat with every meal. Don't skip meals.
Hydration
Dehydration impairs cellular function. Add a pinch of sea salt to your water for electrolytes.
Condition-specific tips
Work with a dietitian experienced in short bowel syndrome - standard nutrition advice doesn't apply
Hydration and electrolytes are critical - you lose more than normal bowel patients
Monitor stool losses - they tell you what you're absorbing. Dark yellow stools often indicate better absorption.
Keep a food diary tied to stool pattern - you'll quickly identify your tolerances
Gradual advancement of diet as tolerance improves - don't rush introducing difficult foods
Some foods stimulate more secretion and output (spicy, high fat, high sugar) - identify your triggers
Support nutrients
L-glutamine · 10-30 g daily
Primary fuel for intestinal epithelial cells during healing
Zinc · 15-30 mg daily
Critical for mucosal healing and immune function
Vitamin B12 · As needed based on labs
Often malabsorbed in short bowel - may need injections
Fat-soluble vitamins (A,D,E,K) · Per labs and absorption status
Often malabsorbed - supplementation frequently needed
Calcium and magnesium · Based on labs
Often lost in excess stool output
Probiotics · Depends on brand
Support remaining healthy microbiome
Pancreatic enzymes · With meals if needed
Support digestion if pancreatic function is impaired
monitor_heart
Cardiac Rehabilitation
Exercise is Medicine
Exercise in heart failure is counterintuitive to many patients - 'won't it strain my weak heart?' - but the research is clear: supervised physical activity is one of the most powerful interventions. It strengthens the heart, improves blood vessel function, and works synergistically with peptide therapy.
The basics that matter
Start slow and progress gradually
Formal cardiac rehab programs are ideal. They monitor your heart and progress safely. Start with 10-15 minutes of walking, gradually increase.
Mix aerobic and strength
Walking or cycling builds aerobic capacity. Light resistance training builds muscle mass that supports metabolism.
Consistency over intensity
30 minutes of moderate activity most days is far better than occasional intense workouts. Aim for 150 minutes per week of moderate activity.
Know your limits
Exertional dyspnea (breathlessness) is your signal to slow down. You should be able to talk while exercising (the 'talk test').
Condition-specific tips
Don't overdo it during early phases - your body is healing internally
Excessive activity increases stool output and losses
Wait 1-2 hours after meals before vigorous activity
Stay hydrated during activity - you lose more fluids than normal
Listen to your body - if you crash afterward, you overdid it
What to keep in mind.
check_circle
FDA-Approved Efficacy
Teduglutide is FDA-approved specifically for short bowel syndrome with documented clinical benefit. This is proven therapy, not experimental.
warning
Not a Cure
These peptides support your remaining intestine's adaptation. They cannot regenerate surgically removed tissue. The goal is optimizing what remains.
stethoscope
Professional Monitoring Essential
Work closely with your gastroenterology team, PN specialist, and possibly a dietitian. Blood work, stool output tracking, and clinical assessment guide treatment.
trending_up
Variable Response
Clinical trials show ~60% of patients achieve clinically significant PN reduction. Individual results vary based on length of remaining bowel, health status, and other factors.
vaccines
PN Remains Vital
Even with successful teduglutide treatment, many patients need some supplemental nutrition. Don't view PN as failure - it's supportive therapy until intestinal function optimizes.
This information is for educational purposes only and should not be considered medical advice. Always consult with a qualified healthcare provider before starting any new treatment.
Peptide
What it does
Typical dose
Timing
Teduglutide (Gattex)
FDA-Approved Intestinal Growth Factor
0.05 mg/kg once daily
Once daily subcutaneous injection
GLP-2 Analogs (Teduglutide)
Natural Gut Growth Signals
0.05 mg/kg daily
Daily dosing provides consistent stimulation of adaptation
Can be taken at any time, though morning dosing is often preferred
Early wins to watch
trending_upImproved stool consistency
trending_upReduced diarrhea frequency
trending_upBetter food tolerance
trending_upMeasurable PN reduction on lab tests
Support stack
L-glutamine (intestinal fuel)
Zinc (mucosal healing)
Vitamin B12 (often absorbed poorly)
Fat-soluble vitamins A, D, E, K
Probiotics (microbiome support)
Pancreatic enzymes (if needed)
Calcium and magnesium
Lifestyle priorities
1Frequent small meals
2Hydration and electrolytes
3Gentle movement daily
4Stress management
5Sleep optimization
6Consistent monitoring
Short bowel syndrome is serious - it fundamentally changes how your body nourishes itself. But teduglutide represents a real opportunity to reclaim function you've lost. The goal isn't to replace what was surgically removed; it's to maximize what remains. For many patients, this means reducing or eliminating PN dependence, regaining freedom, and avoiding PN-related complications like liver disease and infections. The journey requires patience, careful monitoring, and partnership with your medical team. But functional improvement is possible.
You didn't choose this condition, but teduglutide gives you a choice in how you respond to it. Work with your team, track your progress carefully, and give your remaining intestine time to heal and adapt.
0.05 mg/kg once dailyTeduglutide (Gattex) · typical range in this guide